Using T Cells to Diagnose Lung Cancer Early
Author Information
Author(s): Lee Sung-Woo, Kim Young Ju, Rho Kyung Na, Jeong Saei, Noh Jeong Eun, Kim Hee-Ok, Cho Hyun-Ju, Yun Ju Sik, Oh In-Jae, Cho Jae-Ho
Primary Institution: Chonnam National University Medical School
Hypothesis
Measuring cancer-associated immune alterations in the circulation could indicate the presence of a tumor, serving as a diagnostic biomarker.
Conclusion
The study suggests that analyzing changes in circulating T cells can effectively detect lung cancer from its early stages.
Supporting Evidence
- The study analyzed 452 blood samples to identify T-cell features relevant for lung cancer diagnosis.
- Five T-cell features were found to be significantly altered in lung cancer patients compared to controls.
- The IMPACT scoring model demonstrated high specificity for lung cancer detection.
Takeaway
Doctors can look at special changes in blood cells to find lung cancer early, which can help save lives.
Methodology
The study involved flow cytometric analysis of peripheral blood mononuclear cells from lung cancer patients and controls to identify T-cell features with diagnostic relevance.
Limitations
The individual alterations in T-cell features lacked cancer specificity, and 60-70% of non-cancer controls exhibited elevations in at least one feature.
Participant Demographics
206 non-small-cell lung cancer patients, 100 small-cell lung cancer patients, 94 healthy individuals, and 52 benign lung disease patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website